0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative

0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Antihelminthics Market Research Report 2025
Published Date: September 2025
|
Report Code: QYRE-Auto-32V6933
Home | Market Reports | Health| Pharmacy
Global Antihelminthics Market Insights and Forecast to 2028
BUY CHAPTERS

Global Antihelminthics Market Research Report 2025

Code: QYRE-Auto-32V6933
Report
September 2025
Pages:92
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES

Antihelminthics Market Size

The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years.

Antihelminthics Market

Antihelminthics Market

The global market for Antihelminthics was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.
Anthelmintics or antihelminthics are a group of antiparasitic drugs that expel parasitic worms (helminths) and other internal parasites from the body by either stunning or killing them and without causing significant damage to the host.
The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Antihelminthics, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Antihelminthics.
The Antihelminthics market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Antihelminthics market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Antihelminthics manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Scope of Antihelminthics Market Report

Report Metric Details
Report Name Antihelminthics Market
CAGR 5%
Segment by Type
Segment by Application
Consumption by Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia)
  • Asia-Pacific (China, Japan, South Korea, Taiwan)
  • Southeast Asia (India)
  • Latin America (Mexico, Brazil)
By Company Abbott, Novartis, ZEISS International, Johnson & Johnson, Sanofi, Merck & Co., GlaxoSmithKline, Astellas Pharma, Bayer, Mentis Pharma, Pfizer, ALLERGAN, AstraZeneca
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Core Chapters

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter 2: Detailed analysis of Antihelminthics manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 3: Sales, revenue of Antihelminthics in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
  • Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
  • Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
  • Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
  • Chapter 9: The main points and conclusions of the report. 

FAQ for this report

Who are the main players in the Antihelminthics Market report?

Ans: The main players in the Antihelminthics Market are Abbott, Novartis, ZEISS International, Johnson & Johnson, Sanofi, Merck & Co., GlaxoSmithKline, Astellas Pharma, Bayer, Mentis Pharma, Pfizer, ALLERGAN, AstraZeneca

What are the Application segmentation covered in the Antihelminthics Market report?

Ans: The Applications covered in the Antihelminthics Market report are Schistosomiasis, Fasciolasis, Filariasis, Angiostrongylosis, Ascariasis, Giardiasis, Other

What are the Type segmentation covered in the Antihelminthics Market report?

Ans: The Types covered in the Antihelminthics Market report are Benzimidazoles, Abamectin, Salicylanilides, Praziquantel, Other

Recommended Reports

Antiparasitic Markets

Pharmaceutical Supplements

Diagnosis & Treatment

1 Antihelminthics Market Overview
1.1 Product Definition
1.2 Antihelminthics by Type
1.2.1 Global Antihelminthics Market Value Comparison by Type (2024 VS 2031)
1.2.2 Benzimidazoles
1.2.3 Abamectin
1.2.4 Salicylanilides
1.2.5 Praziquantel
1.2.6 Other
1.3 Antihelminthics by Application
1.3.1 Global Antihelminthics Market Value by Application (2024 VS 2031)
1.3.2 Schistosomiasis
1.3.3 Fasciolasis
1.3.4 Filariasis
1.3.5 Angiostrongylosis
1.3.6 Ascariasis
1.3.7 Giardiasis
1.3.8 Other
1.4 Global Antihelminthics Market Size Estimates and Forecasts
1.4.1 Global Antihelminthics Revenue 2020-2031
1.4.2 Global Antihelminthics Sales 2020-2031
1.4.3 Global Antihelminthics Market Average Price (2020-2031)
1.5 Assumptions and Limitations
2 Antihelminthics Market Competition by Manufacturers
2.1 Global Antihelminthics Sales Market Share by Manufacturers (2020-2025)
2.2 Global Antihelminthics Revenue Market Share by Manufacturers (2020-2025)
2.3 Global Antihelminthics Average Price by Manufacturers (2020-2025)
2.4 Global Key Players of Antihelminthics, Industry Ranking, 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Antihelminthics, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Antihelminthics, Product Type & Application
2.7 Global Key Manufacturers of Antihelminthics, Date of Enter into This Industry
2.8 Global Antihelminthics Market Competitive Situation and Trends
2.8.1 Global Antihelminthics Market Concentration Rate
2.8.2 The Global 5 and 10 Largest Antihelminthics Players Market Share by Revenue
2.8.3 Global Antihelminthics Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
2.9 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Global Antihelminthics Market Scenario by Region
3.1 Global Antihelminthics Market Size by Region: 2020 Versus 2024 Versus 2031
3.2 Global Antihelminthics Sales by Region: 2020-2031
3.2.1 Global Antihelminthics Sales by Region: 2020-2025
3.2.2 Global Antihelminthics Sales by Region: 2026-2031
3.3 Global Antihelminthics Revenue by Region: 2020-2031
3.3.1 Global Antihelminthics Revenue by Region: 2020-2025
3.3.2 Global Antihelminthics Revenue by Region: 2026-2031
3.4 North America Antihelminthics Market Facts & Figures by Country
3.4.1 North America Antihelminthics Market Size by Country: 2020 VS 2024 VS 2031
3.4.2 North America Antihelminthics Sales by Country (2020-2031)
3.4.3 North America Antihelminthics Revenue by Country (2020-2031)
3.4.4 U.S.
3.4.5 Canada
3.5 Europe Antihelminthics Market Facts & Figures by Country
3.5.1 Europe Antihelminthics Market Size by Country: 2020 VS 2024 VS 2031
3.5.2 Europe Antihelminthics Sales by Country (2020-2031)
3.5.3 Europe Antihelminthics Revenue by Country (2020-2031)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Antihelminthics Market Facts & Figures by Region
3.6.1 Asia Pacific Antihelminthics Market Size by Region: 2020 VS 2024 VS 2031
3.6.2 Asia Pacific Antihelminthics Sales by Region (2020-2031)
3.6.3 Asia Pacific Antihelminthics Revenue by Region (2020-2031)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.6.13 Philippines
3.7 Latin America Antihelminthics Market Facts & Figures by Country
3.7.1 Latin America Antihelminthics Market Size by Country: 2020 VS 2024 VS 2031
3.7.2 Latin America Antihelminthics Sales by Country (2020-2031)
3.7.3 Latin America Antihelminthics Revenue by Country (2020-2031)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Antihelminthics Market Facts & Figures by Country
3.8.1 Middle East and Africa Antihelminthics Market Size by Country: 2020 VS 2024 VS 2031
3.8.2 Middle East and Africa Antihelminthics Sales by Country (2020-2031)
3.8.3 Middle East and Africa Antihelminthics Revenue by Country (2020-2031)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 U.A.E
4 Segment by Type
4.1 Global Antihelminthics Sales by Type (2020-2031)
4.1.1 Global Antihelminthics Sales by Type (2020-2025)
4.1.2 Global Antihelminthics Sales by Type (2026-2031)
4.1.3 Global Antihelminthics Sales Market Share by Type (2020-2031)
4.2 Global Antihelminthics Revenue by Type (2020-2031)
4.2.1 Global Antihelminthics Revenue by Type (2020-2025)
4.2.2 Global Antihelminthics Revenue by Type (2026-2031)
4.2.3 Global Antihelminthics Revenue Market Share by Type (2020-2031)
4.3 Global Antihelminthics Price by Type (2020-2031)
5 Segment by Application
5.1 Global Antihelminthics Sales by Application (2020-2031)
5.1.1 Global Antihelminthics Sales by Application (2020-2025)
5.1.2 Global Antihelminthics Sales by Application (2026-2031)
5.1.3 Global Antihelminthics Sales Market Share by Application (2020-2031)
5.2 Global Antihelminthics Revenue by Application (2020-2031)
5.2.1 Global Antihelminthics Revenue by Application (2020-2025)
5.2.2 Global Antihelminthics Revenue by Application (2026-2031)
5.2.3 Global Antihelminthics Revenue Market Share by Application (2020-2031)
5.3 Global Antihelminthics Price by Application (2020-2031)
6 Key Companies Profiled
6.1 Abbott
6.1.1 Abbott Company Information
6.1.2 Abbott Description and Business Overview
6.1.3 Abbott Antihelminthics Sales, Revenue and Gross Margin (2020-2025)
6.1.4 Abbott Antihelminthics Product Portfolio
6.1.5 Abbott Recent Developments/Updates
6.2 Novartis
6.2.1 Novartis Company Information
6.2.2 Novartis Description and Business Overview
6.2.3 Novartis Antihelminthics Sales, Revenue and Gross Margin (2020-2025)
6.2.4 Novartis Antihelminthics Product Portfolio
6.2.5 Novartis Recent Developments/Updates
6.3 ZEISS International
6.3.1 ZEISS International Company Information
6.3.2 ZEISS International Description and Business Overview
6.3.3 ZEISS International Antihelminthics Sales, Revenue and Gross Margin (2020-2025)
6.3.4 ZEISS International Antihelminthics Product Portfolio
6.3.5 ZEISS International Recent Developments/Updates
6.4 Johnson & Johnson
6.4.1 Johnson & Johnson Company Information
6.4.2 Johnson & Johnson Description and Business Overview
6.4.3 Johnson & Johnson Antihelminthics Sales, Revenue and Gross Margin (2020-2025)
6.4.4 Johnson & Johnson Antihelminthics Product Portfolio
6.4.5 Johnson & Johnson Recent Developments/Updates
6.5 Sanofi
6.5.1 Sanofi Company Information
6.5.2 Sanofi Description and Business Overview
6.5.3 Sanofi Antihelminthics Sales, Revenue and Gross Margin (2020-2025)
6.5.4 Sanofi Antihelminthics Product Portfolio
6.5.5 Sanofi Recent Developments/Updates
6.6 Merck & Co.
6.6.1 Merck & Co. Company Information
6.6.2 Merck & Co. Description and Business Overview
6.6.3 Merck & Co. Antihelminthics Sales, Revenue and Gross Margin (2020-2025)
6.6.4 Merck & Co. Antihelminthics Product Portfolio
6.6.5 Merck & Co. Recent Developments/Updates
6.7 GlaxoSmithKline
6.7.1 GlaxoSmithKline Company Information
6.7.2 GlaxoSmithKline Description and Business Overview
6.7.3 GlaxoSmithKline Antihelminthics Sales, Revenue and Gross Margin (2020-2025)
6.7.4 GlaxoSmithKline Antihelminthics Product Portfolio
6.7.5 GlaxoSmithKline Recent Developments/Updates
6.8 Astellas Pharma
6.8.1 Astellas Pharma Company Information
6.8.2 Astellas Pharma Description and Business Overview
6.8.3 Astellas Pharma Antihelminthics Sales, Revenue and Gross Margin (2020-2025)
6.8.4 Astellas Pharma Antihelminthics Product Portfolio
6.8.5 Astellas Pharma Recent Developments/Updates
6.9 Bayer
6.9.1 Bayer Company Information
6.9.2 Bayer Description and Business Overview
6.9.3 Bayer Antihelminthics Sales, Revenue and Gross Margin (2020-2025)
6.9.4 Bayer Antihelminthics Product Portfolio
6.9.5 Bayer Recent Developments/Updates
6.10 Mentis Pharma
6.10.1 Mentis Pharma Company Information
6.10.2 Mentis Pharma Description and Business Overview
6.10.3 Mentis Pharma Antihelminthics Sales, Revenue and Gross Margin (2020-2025)
6.10.4 Mentis Pharma Antihelminthics Product Portfolio
6.10.5 Mentis Pharma Recent Developments/Updates
6.11 Pfizer
6.11.1 Pfizer Company Information
6.11.2 Pfizer Description and Business Overview
6.11.3 Pfizer Antihelminthics Sales, Revenue and Gross Margin (2020-2025)
6.11.4 Pfizer Antihelminthics Product Portfolio
6.11.5 Pfizer Recent Developments/Updates
6.12 Sanofi
6.12.1 Sanofi Company Information
6.12.2 Sanofi Description and Business Overview
6.12.3 Sanofi Antihelminthics Sales, Revenue and Gross Margin (2020-2025)
6.12.4 Sanofi Antihelminthics Product Portfolio
6.12.5 Sanofi Recent Developments/Updates
6.13 ALLERGAN
6.13.1 ALLERGAN Company Information
6.13.2 ALLERGAN Description and Business Overview
6.13.3 ALLERGAN Antihelminthics Sales, Revenue and Gross Margin (2020-2025)
6.13.4 ALLERGAN Antihelminthics Product Portfolio
6.13.5 ALLERGAN Recent Developments/Updates
6.14 AstraZeneca
6.14.1 AstraZeneca Company Information
6.14.2 AstraZeneca Description and Business Overview
6.14.3 AstraZeneca Antihelminthics Sales, Revenue and Gross Margin (2020-2025)
6.14.4 AstraZeneca Antihelminthics Product Portfolio
6.14.5 AstraZeneca Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Antihelminthics Industry Chain Analysis
7.2 Antihelminthics Raw Material Supply Analysis
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Antihelminthics Production Mode & Process Analysis
7.4 Antihelminthics Sales and Marketing
7.4.1 Antihelminthics Sales Channels
7.4.2 Antihelminthics Distributors
7.5 Antihelminthics Customer Analysis
8 Antihelminthics Market Dynamics
8.1 Antihelminthics Industry Trends
8.2 Antihelminthics Market Drivers
8.3 Antihelminthics Market Challenges
8.4 Antihelminthics Market Restraints
9 Research Findings and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
List of Tables
 Table 1. Global Antihelminthics Market Value Comparison by Type (2024 VS 2031) & (US$ Million)
 Table 2. Global Antihelminthics Market Value by Application (2024 VS 2031) & (US$ Million)
 Table 3. Global Antihelminthics Market Competitive Situation by Manufacturers in 2024
 Table 4. Global Antihelminthics Sales (K Units) of Key Manufacturers (2020-2025)
 Table 5. Global Antihelminthics Sales Market Share by Manufacturers (2020-2025)
 Table 6. Global Antihelminthics Revenue (US$ Million) by Manufacturers (2020-2025)
 Table 7. Global Antihelminthics Revenue Share by Manufacturers (2020-2025)
 Table 8. Global Market Antihelminthics Average Price (USD/Unit) of Key Manufacturers (2020-2025)
 Table 9. Global Key Players of Antihelminthics, Industry Ranking, 2022 VS 2023 VS 2024
 Table 10. Global Key Manufacturers of Antihelminthics, Manufacturing Sites & Headquarters
 Table 11. Global Key Manufacturers of Antihelminthics, Product Type & Application
 Table 12. Global Key Manufacturers of Antihelminthics, Date of Enter into This Industry
 Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
 Table 14. Global Antihelminthics by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Antihelminthics as of 2024)
 Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
 Table 16. Global Antihelminthics Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Table 17. Global Antihelminthics Sales by Region (2020-2025) & (K Units)
 Table 18. Global Antihelminthics Sales Market Share by Region (2020-2025)
 Table 19. Global Antihelminthics Sales by Region (2026-2031) & (K Units)
 Table 20. Global Antihelminthics Sales Market Share by Region (2026-2031)
 Table 21. Global Antihelminthics Revenue by Region (2020-2025) & (US$ Million)
 Table 22. Global Antihelminthics Revenue Market Share by Region (2020-2025)
 Table 23. Global Antihelminthics Revenue by Region (2026-2031) & (US$ Million)
 Table 24. Global Antihelminthics Revenue Market Share by Region (2026-2031)
 Table 25. North America Antihelminthics Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 26. North America Antihelminthics Sales by Country (2020-2025) & (K Units)
 Table 27. North America Antihelminthics Sales by Country (2026-2031) & (K Units)
 Table 28. North America Antihelminthics Revenue by Country (2020-2025) & (US$ Million)
 Table 29. North America Antihelminthics Revenue by Country (2026-2031) & (US$ Million)
 Table 30. Europe Antihelminthics Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 31. Europe Antihelminthics Sales by Country (2020-2025) & (K Units)
 Table 32. Europe Antihelminthics Sales by Country (2026-2031) & (K Units)
 Table 33. Europe Antihelminthics Revenue by Country (2020-2025) & (US$ Million)
 Table 34. Europe Antihelminthics Revenue by Country (2026-2031) & (US$ Million)
 Table 35. Asia Pacific Antihelminthics Revenue by Region: 2020 VS 2024 VS 2031 (US$ Million)
 Table 36. Asia Pacific Antihelminthics Sales by Region (2020-2025) & (K Units)
 Table 37. Asia Pacific Antihelminthics Sales by Region (2026-2031) & (K Units)
 Table 38. Asia Pacific Antihelminthics Revenue by Region (2020-2025) & (US$ Million)
 Table 39. Asia Pacific Antihelminthics Revenue by Region (2026-2031) & (US$ Million)
 Table 40. Latin America Antihelminthics Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 41. Latin America Antihelminthics Sales by Country (2020-2025) & (K Units)
 Table 42. Latin America Antihelminthics Sales by Country (2026-2031) & (K Units)
 Table 43. Latin America Antihelminthics Revenue by Country (2020-2025) & (US$ Million)
 Table 44. Latin America Antihelminthics Revenue by Country (2026-2031) & (US$ Million)
 Table 45. Middle East and Africa Antihelminthics Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 46. Middle East and Africa Antihelminthics Sales by Country (2020-2025) & (K Units)
 Table 47. Middle East and Africa Antihelminthics Sales by Country (2026-2031) & (K Units)
 Table 48. Middle East and Africa Antihelminthics Revenue by Country (2020-2025) & (US$ Million)
 Table 49. Middle East and Africa Antihelminthics Revenue by Country (2026-2031) & (US$ Million)
 Table 50. Global Antihelminthics Sales (K Units) by Type (2020-2025)
 Table 51. Global Antihelminthics Sales (K Units) by Type (2026-2031)
 Table 52. Global Antihelminthics Sales Market Share by Type (2020-2025)
 Table 53. Global Antihelminthics Sales Market Share by Type (2026-2031)
 Table 54. Global Antihelminthics Revenue (US$ Million) by Type (2020-2025)
 Table 55. Global Antihelminthics Revenue (US$ Million) by Type (2026-2031)
 Table 56. Global Antihelminthics Revenue Market Share by Type (2020-2025)
 Table 57. Global Antihelminthics Revenue Market Share by Type (2026-2031)
 Table 58. Global Antihelminthics Price (USD/Unit) by Type (2020-2025)
 Table 59. Global Antihelminthics Price (USD/Unit) by Type (2026-2031)
 Table 60. Global Antihelminthics Sales (K Units) by Application (2020-2025)
 Table 61. Global Antihelminthics Sales (K Units) by Application (2026-2031)
 Table 62. Global Antihelminthics Sales Market Share by Application (2020-2025)
 Table 63. Global Antihelminthics Sales Market Share by Application (2026-2031)
 Table 64. Global Antihelminthics Revenue (US$ Million) by Application (2020-2025)
 Table 65. Global Antihelminthics Revenue (US$ Million) by Application (2026-2031)
 Table 66. Global Antihelminthics Revenue Market Share by Application (2020-2025)
 Table 67. Global Antihelminthics Revenue Market Share by Application (2026-2031)
 Table 68. Global Antihelminthics Price (USD/Unit) by Application (2020-2025)
 Table 69. Global Antihelminthics Price (USD/Unit) by Application (2026-2031)
 Table 70. Abbott Company Information
 Table 71. Abbott Description and Business Overview
 Table 72. Abbott Antihelminthics Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
 Table 73. Abbott Antihelminthics Product
 Table 74. Abbott Recent Developments/Updates
 Table 75. Novartis Company Information
 Table 76. Novartis Description and Business Overview
 Table 77. Novartis Antihelminthics Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
 Table 78. Novartis Antihelminthics Product
 Table 79. Novartis Recent Developments/Updates
 Table 80. ZEISS International Company Information
 Table 81. ZEISS International Description and Business Overview
 Table 82. ZEISS International Antihelminthics Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
 Table 83. ZEISS International Antihelminthics Product
 Table 84. ZEISS International Recent Developments/Updates
 Table 85. Johnson & Johnson Company Information
 Table 86. Johnson & Johnson Description and Business Overview
 Table 87. Johnson & Johnson Antihelminthics Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
 Table 88. Johnson & Johnson Antihelminthics Product
 Table 89. Johnson & Johnson Recent Developments/Updates
 Table 90. Sanofi Company Information
 Table 91. Sanofi Description and Business Overview
 Table 92. Sanofi Antihelminthics Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
 Table 93. Sanofi Antihelminthics Product
 Table 94. Sanofi Recent Developments/Updates
 Table 95. Merck & Co. Company Information
 Table 96. Merck & Co. Description and Business Overview
 Table 97. Merck & Co. Antihelminthics Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
 Table 98. Merck & Co. Antihelminthics Product
 Table 99. Merck & Co. Recent Developments/Updates
 Table 100. GlaxoSmithKline Company Information
 Table 101. GlaxoSmithKline Description and Business Overview
 Table 102. GlaxoSmithKline Antihelminthics Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
 Table 103. GlaxoSmithKline Antihelminthics Product
 Table 104. GlaxoSmithKline Recent Developments/Updates
 Table 105. Astellas Pharma Company Information
 Table 106. Astellas Pharma Description and Business Overview
 Table 107. Astellas Pharma Antihelminthics Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
 Table 108. Astellas Pharma Antihelminthics Product
 Table 109. Astellas Pharma Recent Developments/Updates
 Table 110. Bayer Company Information
 Table 111. Bayer Description and Business Overview
 Table 112. Bayer Antihelminthics Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
 Table 113. Bayer Antihelminthics Product
 Table 114. Bayer Recent Developments/Updates
 Table 115. Mentis Pharma Company Information
 Table 116. Mentis Pharma Description and Business Overview
 Table 117. Mentis Pharma Antihelminthics Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
 Table 118. Mentis Pharma Antihelminthics Product
 Table 119. Mentis Pharma Recent Developments/Updates
 Table 120. Pfizer Company Information
 Table 121. Pfizer Description and Business Overview
 Table 122. Pfizer Antihelminthics Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
 Table 123. Pfizer Antihelminthics Product
 Table 124. Pfizer Recent Developments/Updates
 Table 125. Sanofi Company Information
 Table 126. Sanofi Description and Business Overview
 Table 127. Sanofi Antihelminthics Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
 Table 128. Sanofi Antihelminthics Product
 Table 129. Sanofi Recent Developments/Updates
 Table 130. ALLERGAN Company Information
 Table 131. ALLERGAN Description and Business Overview
 Table 132. ALLERGAN Antihelminthics Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
 Table 133. ALLERGAN Antihelminthics Product
 Table 134. ALLERGAN Recent Developments/Updates
 Table 135. AstraZeneca Company Information
 Table 136. AstraZeneca Description and Business Overview
 Table 137. AstraZeneca Antihelminthics Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
 Table 138. AstraZeneca Antihelminthics Product
 Table 139. AstraZeneca Recent Developments/Updates
 Table 140. Key Raw Materials Lists
 Table 141. Raw Materials Key Suppliers Lists
 Table 142. Antihelminthics Distributors List
 Table 143. Antihelminthics Customers List
 Table 144. Antihelminthics Market Trends
 Table 145. Antihelminthics Market Drivers
 Table 146. Antihelminthics Market Challenges
 Table 147. Antihelminthics Market Restraints
 Table 148. Research Programs/Design for This Report
 Table 149. Key Data Information from Secondary Sources
 Table 150. Key Data Information from Primary Sources
 Table 151. Authors List of This Report


List of Figures
 Figure 1. Product Picture of Antihelminthics
 Figure 2. Global Antihelminthics Market Value Comparison by Type (2020-2031) & (US$ Million)
 Figure 3. Global Antihelminthics Market Share by Type: 2024 & 2031
 Figure 4. Benzimidazoles Product Picture
 Figure 5. Abamectin Product Picture
 Figure 6. Salicylanilides Product Picture
 Figure 7. Praziquantel Product Picture
 Figure 8. Other Product Picture
 Figure 9. Global Antihelminthics Market Value by Application (2020-2031) & (US$ Million)
 Figure 10. Global Antihelminthics Market Share by Application: 2024 & 2031
 Figure 11. Schistosomiasis
 Figure 12. Fasciolasis
 Figure 13. Filariasis
 Figure 14. Angiostrongylosis
 Figure 15. Ascariasis
 Figure 16. Giardiasis
 Figure 17. Other
 Figure 18. Global Antihelminthics Revenue, (US$ Million), 2020 VS 2024 VS 2031
 Figure 19. Global Antihelminthics Market Size (2020-2031) & (US$ Million)
 Figure 20. Global Antihelminthics Sales (2020-2031) & (K Units)
 Figure 21. Global Antihelminthics Average Price (USD/Unit) & (2020-2031)
 Figure 22. Antihelminthics Report Years Considered
 Figure 23. Antihelminthics Sales Share by Manufacturers in 2024
 Figure 24. Global Antihelminthics Revenue Share by Manufacturers in 2024
 Figure 25. Global 5 and 10 Largest Antihelminthics Players: Market Share by Revenue in Antihelminthics in 2024
 Figure 26. Antihelminthics Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
 Figure 27. Global Antihelminthics Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Figure 28. North America Antihelminthics Sales Market Share by Country (2020-2031)
 Figure 29. North America Antihelminthics Revenue Market Share by Country (2020-2031)
 Figure 30. U.S. Antihelminthics Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 31. Canada Antihelminthics Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 32. Europe Antihelminthics Sales Market Share by Country (2020-2031)
 Figure 33. Europe Antihelminthics Revenue Market Share by Country (2020-2031)
 Figure 34. Germany Antihelminthics Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 35. France Antihelminthics Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 36. U.K. Antihelminthics Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 37. Italy Antihelminthics Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 38. Russia Antihelminthics Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 39. Asia Pacific Antihelminthics Sales Market Share by Region (2020-2031)
 Figure 40. Asia Pacific Antihelminthics Revenue Market Share by Region (2020-2031)
 Figure 41. China Antihelminthics Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 42. Japan Antihelminthics Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 43. South Korea Antihelminthics Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 44. India Antihelminthics Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 45. Australia Antihelminthics Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 46. Taiwan Antihelminthics Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 47. Indonesia Antihelminthics Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 48. Thailand Antihelminthics Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 49. Malaysia Antihelminthics Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 50. Philippines Antihelminthics Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 51. Latin America Antihelminthics Sales Market Share by Country (2020-2031)
 Figure 52. Latin America Antihelminthics Revenue Market Share by Country (2020-2031)
 Figure 53. Mexico Antihelminthics Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 54. Brazil Antihelminthics Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 55. Argentina Antihelminthics Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 56. Middle East and Africa Antihelminthics Sales Market Share by Country (2020-2031)
 Figure 57. Middle East and Africa Antihelminthics Revenue Market Share by Country (2020-2031)
 Figure 58. Turkey Antihelminthics Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 59. Saudi Arabia Antihelminthics Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 60. U.A.E Antihelminthics Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 61. Global Sales Market Share of Antihelminthics by Type (2020-2031)
 Figure 62. Global Revenue Market Share of Antihelminthics by Type (2020-2031)
 Figure 63. Global Antihelminthics Price (USD/Unit) by Type (2020-2031)
 Figure 64. Global Sales Market Share of Antihelminthics by Application (2020-2031)
 Figure 65. Global Revenue Market Share of Antihelminthics by Application (2020-2031)
 Figure 66. Global Antihelminthics Price (USD/Unit) by Application (2020-2031)
 Figure 67. Antihelminthics Value Chain
 Figure 68. Channels of Distribution (Direct Vs Distribution)
 Figure 69. Bottom-up and Top-down Approaches for This Report
 Figure 70. Data Triangulation
 Figure 71. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$2900

This license allows only one user to access the PDF.
Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)

OUR CUSTOMER

Novocure

SIMILAR REPORTS